BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 17346160)

  • 1. The effect of ageing on cytochrome p450 enzymes: consequences for drug biotransformation in the elderly.
    Wauthier V; Verbeeck RK; Calderon PB
    Curr Med Chem; 2007; 14(7):745-57. PubMed ID: 17346160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug Metabolism in the Liver.
    Almazroo OA; Miah MK; Venkataramanan R
    Clin Liver Dis; 2017 Feb; 21(1):1-20. PubMed ID: 27842765
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactions and drug-metabolizing enzymes.
    Ciummo PE; Katz NL
    Am Pharm; 1995 Sep; NS35(9):41-51; quiz 51-3. PubMed ID: 7484817
    [No Abstract]   [Full Text] [Related]  

  • 4. Cytochrome P450s: mechanisms and biological implications in drug metabolism and its interaction with oxidative stress.
    Bhattacharyya S; Sinha K; Sil PC
    Curr Drug Metab; 2014; 15(7):719-42. PubMed ID: 25429675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive responses of the liver to foreign compounds, with special reference to microsomal drug-matabolizing enzymes.
    Wada O; Yano Y
    Rev Environ Health; 1974; 1(4):261-82. PubMed ID: 4617260
    [No Abstract]   [Full Text] [Related]  

  • 6. Interplay of Drug-Metabolizing Enzymes and Transporters in Drug Absorption and Disposition.
    Shi S; Li Y
    Curr Drug Metab; 2014; 15(10):915-41. PubMed ID: 25828591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytochrome P450-mediated metabolism in the human gut wall.
    Thelen K; Dressman JB
    J Pharm Pharmacol; 2009 May; 61(5):541-58. PubMed ID: 19405992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug metabolism and ageing.
    Kinirons MT; O'Mahony MS
    Br J Clin Pharmacol; 2004 May; 57(5):540-4. PubMed ID: 15089805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative expression of cytochrome P450 isoenzymes in human liver and association with the metabolism of drugs and xenobiotics.
    Forrester LM; Henderson CJ; Glancey MJ; Back DJ; Park BK; Ball SE; Kitteringham NR; McLaren AW; Miles JS; Skett P
    Biochem J; 1992 Jan; 281 ( Pt 2)(Pt 2):359-68. PubMed ID: 1736885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I and phase II drug-metabolizing enzymes are expressed and heterogeneously distributed in the biliary epithelium.
    Lakehal F; Wendum D; Barbu V; Becquemont L; Poupon R; Balladur P; Hannoun L; Ballet F; Beaune PH; Housset C
    Hepatology; 1999 Dec; 30(6):1498-506. PubMed ID: 10573530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of some hypoglycemic herbs on the activity of phase I and II drug-metabolizing enzymes in alloxan-induced diabetic rats.
    Sheweita SA; Newairy AA; Mansour HA; Yousef MI
    Toxicology; 2002 May; 174(2):131-9. PubMed ID: 11985890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genetic polymorphism of the hepatic metabolism of drugs].
    Larrey D; Pessayre D; Benhamou JP
    Gastroenterol Clin Biol; 1985; 9(6-7):522-31. PubMed ID: 3926587
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of cytochrome P450-mediated drug clearance in humans based on the measured activities of selected CYPs.
    Gao J; Wang J; Gao N; Tian X; Zhou J; Fang Y; Zhang HF; Wen Q; Jia LJ; Zou D; Qiao HL
    Biosci Rep; 2017 Dec; 37(6):. PubMed ID: 29054967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ontogenic development of drug-metabolizing enzymes in male chicken liver.
    Coulet M; Eeckhoutte C; Galtier P
    Can J Physiol Pharmacol; 1996 Jan; 74(1):32-7. PubMed ID: 8963950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polymorphic metabolism by functional alterations of human cytochrome P450 enzymes.
    Lee IS; Kim D
    Arch Pharm Res; 2011 Nov; 34(11):1799-816. PubMed ID: 22139682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modulation of cytochrome P450 activity: implications for cancer therapy.
    Scripture CD; Sparreboom A; Figg WD
    Lancet Oncol; 2005 Oct; 6(10):780-9. PubMed ID: 16198984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of inhibitory and regulatory effects of methylenedioxyphenyl compounds on cytochrome P450-dependent drug oxidation.
    Murray M
    Curr Drug Metab; 2000 Jul; 1(1):67-84. PubMed ID: 11467081
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical pharmacologic aspects of cytochrome P-450 dependent biotransformation of drugs].
    Ackermann E
    Pharmazie; 1978 Jul; 33(7):400-6. PubMed ID: 364493
    [No Abstract]   [Full Text] [Related]  

  • 19. Postnatal development of hepatic oxidative, hydrolytic and conjugative drug-metabolizing enzymes in female horses.
    Nebbia C; Dacasto M; Carletti M
    Life Sci; 2004 Feb; 74(13):1605-19. PubMed ID: 14738905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of herbal teas on hepatic drug metabolizing enzymes in rats.
    Maliakal PP; Wanwimolruk S
    J Pharm Pharmacol; 2001 Oct; 53(10):1323-9. PubMed ID: 11697539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.